Bluejay Diagnostics Provides First Quarter 2026 Corporate Update
Bluejay Diagnostics provided a Q1 2026 update highlighting progress in clinical enrollment, manufacturing readiness, and regulatory strategy for its Symphony IL-6 test aimed at rapid sepsis patient monitoring. The company enrolled approximately 680 patients in its pivotal SYMON-II study, advanced manufacturing with contract manufacturer Sanyoseiko,…